2013 .

, 5 (113)

- 5 (113)
1997 .


..
:
..
.. (. . ), .. ,
.. (. ),
.. , .. , .. ,
.. , ..
:
.. (. ), .. (. ),
.. (. ), .. (. ),
.. (. ), .. (. ),
.. (. ), .. (. ),
.. (. ), .. (. ),
.. (. ), .. (. ),
.. (. )
:
050008, . , . , 66.
.: 8 (727) 375-80-57, 8 (727) 375-14-74. : 8 (727) 375-05-29.
E-mail: albina.buharbaeva@mail.ru

.
471 27.03.97.

050022, . , . , 98,
./ 260-67-08
.-. . 11,7. 701001/16. 500 .

. , .
.

, 2013
2

.. , .. .
.........................................................................................................................5
.. , .. , .. , .. , .. .
, .....................................................................................................8
.. , .. , .. , .. .
.........................................................14
.. . ( ) ..........................18
.. . , ( ) ...........21
.. , .. , . , . , . ,
. . ( ) ........25
.. .
- .......................................................................28
.. , .. , .. , .. .
..............................................31
.. , .. , .. , .. .
.......................................................................34
.. , . , . , . , . , . .
,
1 ( ) ..........................................................................................................37
.. , .. , .. , .. , .. ,
.. . ...............42
.. , .. , .. , .. ,
.. , .. , .. , .. . ...............................................................................................................................................46
.. .
..........................................................................................................................................49
.. , .. , .. , .. .
...........52
.. , .. , .. , .. . .........................................................57
.. , .. , .. , .. .
.......................62
.. , .. , .. , .. . .........................................65
.. , .. , .. , .. . ................................................69
.. . -
.......................................................................................................................................................72
.. . - ........74
.. , .. , .. , .. . ............................................................................................................77
.. , .. , .. , .. .
............................................80

.. . ........................................................84
3

.. , .. , .. . - ,
20082012 ...........................................................................................................................87
.. . 2012 ......................................................................91
.. .
2012 . .........................................94
.. . . ........97
.. , .. , .. , .. , .. . ..................................................................................................................................................100
.. , .. , .. , .. .
....................................................................................................................................................102
.. , .. , .. , .. , .. .
- ................................................................................................................................105
.. , .. , .. , .. .
...............................................................................................................................107
.. , .. , .. , . , . ,
. . - - ...........109
.. .
................................................................................................112
.. . ...............................................................................................................................................115
.. . .........118
.. , .. , .. , .. , .. , .. . c
..........................................................................................................121
.. , .. , .. , .. , .. , .. . ..............................................................................................124
.. , .. , .. , .. , .. ,
.. . .............126
.. . - . ........................130
.. , .. , .. , .. , .. .
..............................................................134
.. . ..............137
.. , .. , .. . 4- ..................................................................................140

.. . ...........143



2013, 5 (113)

614.2-058(574)
.. , ..

.
PSI

. (): .
: (), .
.. ,
,
,
, .
( ) .
, 2010 ,
, . , , .
?

,
.
, :
;
/;
;
;
, (
).
5


- .

( ) .
- - . ,
, :
, ,
, , .
. . : 2010 . 12 717,
2011 . 14 333, 2012 . 24 638, : 2010 .
1076,6 , 2011 . 1193,7 , 2012 . 3252,2 .
. , . , :
2010 . 963, 2011 . 3513, 2012 . 4347.
, , , , , ,
. , 0
2009 . 16% (12) 2012 .
.

40% . .
2012 . 371 ,
2010 . 198 .
12 , 2009 . 5.
,
,
.
.
, 2010 . 7 (7,4%),
2012 . 15 (30%). 2012 . 36
. : 35,4 . , 23,6 .
.
, , , 6

 ,

.
:
1 .. - //
. 2013. 184185 (2745827459).
2 . - . 26.07.2012. , Nomad () http://www.
nomad.su/.
3 ,
26.02.2011. http://www.vidal.kz/novosti/.

.. , ..




..
.
,
,
.

( )
.
Summary
S.K. Rahmensheev, M.M. Sauranbaeva
the unified health system as a mechanism for modernization
by providing a competitive environment for better health
of population republic of kazakhstan
The President of the country N. Nazarbaev in front of the Ministry of health of RK concrete
tasks, aimed at achieving the goal of strengthening the health of the nation, where the main are: to
ensure the availability of the guaranteed volume of free medical care, improvement in quality of care,
ensuring the economic efficiency of the rendered medical services are the main goals of the health
system.
Today proposed by the Ministry of health program of the unified national health. system
(hereinafter HMIS) is a unique mechanism for implementing these tasks and modernization of health
care.


2013, 5 (113)

613.2/.3

.. , .. , .. ,
.. , ..
, .

,


. ,
, .
: , , , .
, , ,
,
, - , , ,
. , 60% , [14],
- [5], [6], [7], [8],
II [9] [10].
.

,
.
.
15 , , - . 70 2100
, 30 . (),
2009 , 1200 .
.
,
. 2012 . - - .

1.

57% - , .
8

 (55%) (54%). , .
0,8 13% .
(72%) (36%). 1,2 6,6% .

18.00 21.00 22% 21.00 .

.
13 17, 9 11% .
(60% )
( 31%). 0,4 8,3%
.
, , ,
49,3 38,5%.
90%
, 95%
, 97% .
2. , , , :
, , , , , 59%,
26%, 4,7 8,2% . ,
, .
, , , ,
41%, 39%, 2,2 12,3% . ,
, ,
, - .
, , , , 39%, 15%, 3,5 15% .
, , 40%
, ,
, .
4,4%,
5,7%, 13 24%, 62% . , -
.
4,2%, 16%, 13
39%, 35% . -, 20%
9

 ,
- .
(, , , , , ) 5%, 9%, 13 32%, 42%,
12% . ,
, - .
, 79%, 12%,
2 6% . 20%
, (
, -), ,
.
(, , , , ,
) 41%, 39%,
2,2 12,3% . . , ,
.
,
32%, 44%, 4 20% . 20% ,
( ) .
, , , , 59%, 18%, 8 11% . , 60%
,
, .
, 91%, 6%, 12%
.
(49%) (42%), .
3.
, ,
, , , , ,
24 , ,
( 82 93%) . , , , , - .
, , , , .
, .
, , , , , 10

, 93% .
.
4.

( , , , - , )
24 , , 4 10% .
, ,
. ,

.
, , 74%
16% , .
20% ( ) 86% ( ) (, , , , ,
),
.
. , ,

. .
37% , , 20%
, 19% , 15% , 18%
, 12% .
.
84 87% ,
, .
5.

(92%),
(75%) (99%) . , 94% ,
. ,
.
, 97% ,
89% 91% .

. 2007
11


, .
(31%) ,
(57%) (52%) . 10%
, . ,
.
, 10% , 36% 13 , 62% 2550 34%
. , , 0,03 3,7%.

, .
84%,
81% .
6.
28% - - ,
8% , 5% , 2,1% . , .
0,5 47% ,
, 2 37% , .
. , .
,
80 86% .

,
. ,
, ,
.

,
.
.
12


1 . . 2000. 49 .
2 : . .
. 2005. 32 .
3 : /
. , . 2008. 47 .
4 . . , 2010. 177 .
5 Cardiovascular diseases fact sheet. WHO. 2007. 3 p.
6 Carcinogens and Anticarcinogens in the Human Diet: A Comparison of Naturally Occurring
and Synthetic Substances Committee on Comparative Toxicity of Naturally Occurring Carcinogens,
National Research Council ISBN: 0-309-55659-7, 1996, 436 p. The PDF is available from the National
Academies Press at: http://www.nap.edu/catalog/5150.html.
7 . . . 2009. 408 .
8 Prevention and Management of Osteoporosis. Report of a WHO Scientific Group WHO
Technical Report Series. 2003. No 921. 201 p.
9 Global Prevalence of Diabetes. Estimates for the year 2000 and projections for 2030. Diabetes
care. 2004. Vol. 27, 5. 2004. p. 104753.
10 Vitamin and mineral deficiency. A global progress report. UNICEF, Micronutrient Initiative.
2007. 43 p.

.. , .. , .. ,
.. , ..

, -

- ,
, , ,

.
, , ,
.
Summary
Sh.S. Tazhibayev, A.A. Yergaliyeva, O.V. Dolmatova,
A.P. Carcembayeva, O.K. Mukasheva
EVALUATION OF AWARENESS, FOOD HABITS AND BEHAVIORAL PATTERNS
OF KAZAKHSTAN'S POPULATION ON HEALTHY NUTRITION
Food habits and behavioral patterns, consumption of various food groups, including healthy food,
the levels of public awareness on healthy nutrition and the role of nutrition in prevention of the most
common non-communicable diseases and micronutrient deficiencies in The Republic of Kazakhstan
are characterized. The most advantageous, efficient and having influence forms, channels and time of
information receipt on nutrition are revealed, which should be taken into account in implementation of
communication activities for creation of healthy nutrition patterns of population.

13


2013, 5 (113)

613.2/.3-058.86
.. , .. ,
.. , ..

, .

: .
: , , .


, , .
, .
, -, -, . - , ,
.
, ,
,
. , .
, , ,
( , ), . , .

, , , , - [1, 2].
.
-
.
, ( , , , , 14

 , )
- .
, , ,
,
.
,
, , ,
- .
,
10%- , ,
.
: ,
, , .
: 107 3, 107 3, ,
.
1

, - ,
.
,


,

, -, , - ,
. -
, -


-
-,
,
-
,

080740016719-02-2010,

15

 1
1

, %

, %,
, 0,

, %,

2,8

2,8

23327-98

8090

85

3624-92

9,5

10,15

1065-2002

0,05

0,02
0,05

2,7 4,5

3
-
2,8

0,005

(, , 0,02
)
- 0,01

5867-90

, /,
0,035
51301-2005

51301-2005
26930-86

, /,

26927-86

23452-79

23452-79

137
90

40
25

0,00002

.
.
.
.

(), 3
E.coli, 10
St.aureus, 10

-, ... , 50
, /,

, /,

-

, /,

0,09
, /,

, /

.
.
.

30726-2001
10444.2-94
10.05.035.99

10

<1,0101

30706-2000

10

<1,0101

30706-2000

1107

1107

10.05.035.99

16

KZ 07.00.00304-2009
KZ 07.00.00303-2009
30711-2001
10.05.036-99
10.05.036-99
10.05.036-99
10.05.036-99
30518-97

 , - .


, - .
, 1, , ,
, 1%, .

1 .., .. . .: , 1996. 160 .
2 .., .., .. ./ . ..
. .: , 1985. 246 .
3 .., .., .. :
. .: , 1982. 208 .

.. , .. ,
.. , ..

.
- .
Summary
A.E. Turysbekova, A.B. Toktamysova,
M.O. Kozhahieva, E.K. Asembaeva
THE STUDY OF THE QUALITY AND SAFETY
ON BABY FOOD YOGURT NAMED ""
This article presents the study of the quality and safety of baby food yogurt named "".
Physico-chemical characteristics of the product meet the standard.


2013, 5 (113)

618.3
..
12, .

( )
. . ,
, c ,
.
: , ,
, . ,
. () 0,1 0,7%, 3050 ( 1% ).
, : ,
, , , , , [1].

, , , , , , , , ; .
( )
, ( ,
). ,
. .
,
2 25 .
, , , , , ,
. ,

.
( ) . 95%
[2].
:
(, )
, 3 ., ;
;
18

 ( ) .
( 98%);
(, , , ) (, ) . , .
(), (), - (). , 9096%.
: .
: .
:
1) : ( () );
2) : ; : ;
3) ; ; .
: ( ,
); ( , );
( - , .
. ( ). : , , , ,
, , .
: ; , ,
; ; ; ; ; ; : ,
, , .
.
,

[3, 4].
.
, -, .
, .
III ;
, . , .
,
, ,
.
19

 , (Metyrosine).
,
. [5, 6].
.
, - .
,
.
,
. , .
() , 510
.
. .

-131I- [7, 8].

a- .


.
.
(, ), , , . , b-
,

.
().
5 95% ,
10%. 1 . .
, , . 5 50% [9, 10].
, .
.

1 .. . : , 2007. 233 .
2 .., .. //Consilium medicum: . 2008. . 10, 9. . 9298.
3 Pacak K. et al: Pheochromocytoma: Recommendations for clinical practice from the First
International Symposium // Nat Clin Pract Endocrinol Metab. 2007. 3(92) [PMID: 17237836].
20

4 .., .., ..
. .: , 2002. 200 .
5 Kazic M.R. Perioperative risk factors, morbidity during phaeochromocytoma resection // Acta
Chir. Belg. 2011. Vol. 111, 4. P. 223227.
6 Dan L. Longo, Dennis L. Kasper, J. Larry Jameson, Anthony S. Fauci, Harrison's principles of
internal medicine (18th ed.). New York: McGraw-Hill Medical Publishing Division, 2011. . 240.
7 Erlic Z et al: Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma
patients. //Clin Cancer Res. 2009. 15. . 6378 [PMID: 19825962].
8 .. // 100
. , 2009. . 925933.
9 Manger W. M., Gifford R. W. Pheochromocytoma Current diagnosis and management Clev
Clm.// J Med. 1993. 60. . 365378
10 .., .., .., .. // . ., 2005.

..

( )
,
. .
Summary
D.R. Sifulina
heochromocytoma nd grvidits
(Review of literature)
The most effective and radical treatment of catheholaminproductive tumours is surgery; the
effectiveness of this treatment is quite high. With timely radical surgical treatment the pheochromocytoma
can be fully cured.

616.61-084

2013, 5 (113)
..
, .

,
( )
.
, , ,
,
, , .
: , , , .
, . 21

 , .
39,4% , 30%
29,9% , .
, (37,7%), (50,8%).
:
, ,
,
, .
, . -
. 24
.

. - , , ,
, , ,
[1, 2].

1. ( - )
, .
2. ( )
3. ( ) ( )
4. ( ).
( )
.
. ,
, , 10 000 1 ,
10 .

[3, 4].
. , . -
.
24 .
.
, , , ,
.
,
, , , , . .
, .
, . 13 .
22

 .
, ( ). ,
, ,
( ) [5, 6].
(
) .
, , ,
, (,
). .
, ,
. , [7, 8].
.
, . , ; , ; ,
. , . , (, , , ),
, ,
, , .
. ,
, . .
. , , , . ( ) , ( ). (,
, . .).
, . , ,
.
, [9, 10, 11].
:
;
;
;
;
;
.
,
. ,
, , , .
, .
23


1 .., .., .., .. .
, , ,
. .: , 2002.
2 .., .., .., .. ( ). Ureaplasma urealyticum
// , . 2002. 1. . 815.
3 .. // . 2003. 6. . 255257.
4. .. . .-., , 2005. 300 .
5 .., .. , .
CONSILIUM MEDICUM. 2005.. 07, 7. 250 .
6 .., .., .. , , , . .: -, 2000. 450 .
7 .. : , .
.: , 2002. 200 .
8 .. .
//. .-. 1999. 6. . 779.
9 .. // . . . .
2000. 2 (17). . 124.
10 .., .. // . . . .
2000. 3. . 54.
11 Kong F., Ma Z.,.Gilbert G.L. Journal of Clinical Microbiology, Species identification and
subtyping of Ureaplasma parvum and Ureaplasma urealyticum using PCR-based assay. 2000.
Mar. . 11751179.

..
,
( )

.
,
, , , . - ,
, .
Summary
A.T. Konurkulginov
Ureaplasmosis, ways of prevention
(Review of literature)
In recent years the structure of vaginal infections is connected to ureaplasm that causes ureaplasm
disease. Women ureaplasm disease leads to inflammation and adhesions in the fallopian tubes, and
as a result to infertility and an increased risk of ectopic pregnancy, obesity, cervicitis and salpingooophoritis. Prevention of mycoplasm and ureaplasm diseases is in compliance with the rules of sexual
health and in rejection of casual sex, in such cases the condom must be used.

24

 616.1-08

2013, 5 (113)
.. , .. , . ,
. , . , .

.. , .

( )
. , -
.
: , .
. () ()
.
-
. , - ,

. -
. -
, ,
( )
. ,
20% . , , ,
.
:
1. - , .
2. , . , , [1, 2].

. :
;
;
;
;
;
;
;
(, b2
).
:
;
;
25

 ;
- ;
;
;
().

[3, 4].
:
;
;
;
;
;
;
;
.

. b- , b-
. b-
, , . - ,
. b-
- ,
.
(, ),
b- .
(, , , ..)
(, ).

. () (
) ( ).

,
. , ,
,
. -
.
,
. 20% ,
, . ,

[5].
26


. :
;
;
;
;
.

,
, .

,
.
,
.
, ,
.
() . () [6, 7].
.
( , , ,
, , ..) . -
,
. ,
. .
.
, . ,
,
.

1 . ., . ., . .
. .: , 2005. 243 .
2 . ., . . . .: , 2005. . 454471.
3 .., .., .., .., .., ..,
.. -
// . 2009. 6. . 345351.
4 .., .., .. // . ., 2009. . 40.
27

5 .. // .
. . 1984. 8. . 5759.
6 .. /
.. , H.A. , .. // . 2002. 3. . 144148.
7 ..
// . 2005. ., 13(10) . 6772.

.. , .. , . ,
. , . , .

( )
, () (), .
,
,
.
Summary
A.T. Tursynova, G.A. Otepkali, A. Anashova,
Zh. Alimzhanova, B. Zhumataev, K. Utebaeva
Treatment of hypertension in patients with COPD.
(Review of literature)
High prevalence of conditions such as arterial hypertension (AH) and chronic obstructive
pulmonary disease (COPD), requires the study of these topics. So we have devoted an article analysis
of the literature covering the relationship between COPD and arterial hypertension, their influence on
each other and the treatment of hypertension in patients with COPD.

613.2

2013, 5 (113)
..

-
. - , . . -
.
: - , , , .
- ,
- , 28


.
, ,
, .
[1, 2].

(, , ) ,
, . ,
,
, , .
40
, - [3, 4].
, , ,

. ,
,
,
.

- ,
, - [5].

, ,

.
- (
Lactobacilluscasei Streptococcuslactis), 1:1.
(, , )
.
, , ,
, , ,
.
,
, ,
.
, ,
, , , ,
29

 . , B1, , P- . ,
- 1.
1 -

2,9

1,5

15,0

10,0
,

Na

55,0

134,0

Ca

21,3

50,0

Fe

6,0

Mg

600,0
,

0,5

()

1,0

B1

0,35

B2

0,32

25,0

PP

3,0

100,0 ()

83,0 86,0

,
8386 100,0 .
- .
1. 1 30
- 250330 .
2.

500 150160 .
3.
0,751,0 23 .
, -
- , ,
.
30


1 .., .. // - .
2010. 2 (52). . 3 4.
2 .., .., .., ..
: // . 2006. 2 (52). . 34.
3 .. - // . ()
. 97 2003; 5: 101. Guidelines Committee, // European Society of Hypertension European Society of Cardiology
guidelines for the management of arterial hypertension // J. Hypertens 2003. 9. . 10111053.
4 Boza J.J., Monnoz D., Vuichoud J., Jarret A.R., Gaudard-de-Weck D., Ballvre O. // Protein
hydrolysatevs free amino acid-based diets on the nutritional recovery of the starved rat. // Eur J Nutr.
2000. 39(6). . 23743.

..
-

- , ,
. .

.
Summary
D.V. Edilgiriev
USE OF SOY PRODUCTS IN THE PREVENTION OF ATHEROSCLEROSIS
AND CARDIOVASCULAR DISEASES
The article gives a rationale for the use of soybean in the prevention of cardiovascular disease
in particular atherosclerosis. Proposed product functionality based on soy milk. This article provides
guidance on the use of new soybean fermented milk product in the prevention of atherosclerosis.

340.6_615.015.6_615.099.091

2013, 5 (113)

.. , .. ,
.. , ..
. .. , .

. , .
: - ,
, .
31

 - - ,
[1, 2, 3, 4]. - ,

- . - () ,
, [5].
, - . , .

[6, 7].

.
: ,
, 120 , , 15 30
4,70,3 . - ;
30% .
: , , . .
860,4% , ,
.
740,8% . 390,2%
.
690,5% . 570,3%
, ,
.
:
, .
. , .
32


1 .., .., .., .. . 19961999 . // . ,
2003. 7. . 4041.
2 .., .., .., .., ..,
.. // . , 2010. 4. . 1517.
3 .. . 1999
2010 // . , 2012. . 7685.
4 .., .., .. -
// - . ., 2012. 1. . 3437.
5 Hantson P., Beauloye C. Myocardial metabolism in toxin-induced heart failure and therapeutic
implications // Clin. Toxicol (Phila). 2012. 50(3). . 166171.
6 Kulbitski B.N., Larev Z.V., Fedulova M.V., Denisova O.P., Bogomolov D.V. Pathology of
the heart conducting system in the thanatogenesis of sudden death from alcoholic cardiomyopathy and
coronary heart disease // Sud. med. ekspert. 2012. 55(2). . 6265.
7 Bogomolova I.N., Bogomolov D.V., Shpekht Dlu., Kulbitski B.N. The characteristic
morphological changes of the internal organs in certain forms of combined poisoning. Sud. med.
ekspert. 2012. 55 (2). . 1821.

.. , .. ,
.. , ..




. , ,

,
.
.
Summary
A.Zh. Altayeva, N.V. Selivohina,
M.D. Abuov, B.M. Begaliev
Pathology heart under mortal sharp
and chronic poisoning drug
Results of pathologic-morphological researches of a myocardium and coronary vessels of the
persons who have died of acute poisoning with drugs against chronic narcotic intoxication are presented
in the article. Microscopic research of tissues of heart was conducted with application of passable light
and polarizing microscopy, thus, the revealed pathologic-morphological changes of a myocardium and
coronary vessels at drug addicts were caused by long toxic influence of narcotic substances and alcohol,
and also a chronic hypoxia of tissues, owing to spasm of blood vessels. Degree of expressiveness of
all revealed morphological changes depended on duration of the use of narcotic substances and age of
the dead.

33

 340.6_615.015.6_615.099.091

2013, 5 (113)

.. , .. ,
.. , ..
. .. , .

:
, .
: - ,
, .
(), - ,
, [1]. -
,
, [2, 3]. - ,
- .
- () , ,
[4]. , - .
,
.
[5, 6, 7].

,
.
. 142 ,
-
15 30 , . ( , , ,
, ), 10%-
. , ,
, .
Axio Zeiss A1
Leica DM 750.
34

 .

, , -,
,
.
, , . , ,
.
: , , . , 23
. ,
,
.
. , ,
.
. .
, .
, , ; .
. ,
, . ,
. .
,
: - , , ,
. , .


- ,
. - ,
. ,
- , .
, ,
35

. .

.

1 .. . 1999
2010 // . , 2012, . 7685.
2 .., .., .., .. . 19961999 . // . , 2003. 7, . 4041.
3 .., .., .., .., .., ..

// . , 2010. 4. . 1517.
4 .., .., .. -
// - . ., 2012. 1. . 3437.
5 Hantson P., Beauloye C. Myocardial metabolism in toxin-induced heart failure and therapeutic
implications // Clin. Toxicol (Phila). 2012. 50(3). . 166171.
6 Kulbitski B.N., Larev Z.V., Fedulova M.V., Denisova O.P., Bogomolov D.V. Pathology of
the heart conducting system in the thanatogenesis of sudden death from alcoholic cardiomyopathy and
coronary heart disease // Sud.med.ekspert. 2012. 55(2). 6265.
7 Bogomolova I.N. Bogomolov D.V. Shpekht Dlu., Kulbitski B.N. The characteristic
morphological changes of the internal organs in certain forms of combined poisoning. Sud.med.
ekspert. 2012. 55 (2). 1821.

.. , .. ,
.. , ..



.
. , ,
, , ,
.
.
Summary
A.Zh. Altayeva, N.V. Selivohina,
M.D. Abuov, B.M. Begaliev
Morphological changes of myocardium
at chronic drug intoxication
The article presents the results of morphological changes of myocardium of people who died
because of the chronic narcotic intoxication. The autopsy researches of forensic medical evaluation
revealed the morphological indications of toxic influence in myocardium. Clear blood circulation
disorders, focal damage of myocardium cells with contractures and myocytolysis along with
hypertrophy and atrophy of myocardium cells have been observed. Non-coronary sclerosis is shown as
a characteristic feature.
36

 616.36-002

2013, 5 (113)
.. , . , . ,
. , . , .

. .. , .

,
1
( )
. ( ) 1 C.
: , 1, , ,
, , .
C . 170 (HCV), , C
[1].
. 48
(HCV 1, 4, 5 6) 24 (HCV 2 3),
() 4050% 1
80% 2 3 [24].
HCV, ,
[57].

,
HCV 1: , HCV[815].
, ,
HCV 1.
510
, 1,
, [13]. .
NS3/4A .
NS3/4A, , HCV 1 ,
[9, 10, 13, 14, 16]. 2 , 37

 HCV 2,
3 [21]. , ,
, HCV 2, 3 [22].
HCV 2 3,
, .
[12].
III
. 2011 .
. 2011 (FDA), 2011
() . 2012 .

18
, 1
.
( ) 1 C , ( ).
.

( ) [1720].
.
C ( ) :
7479%;
8488%;
5661%;
-
2933%.
C ( ) :
6366%;
6975%;
4052%;
-
38%.
, , C 1 750 ,
79 . (20 ).
2
38

2 b 12 . 1236
.

, c :
2 180 1 ;
2 b 1,5 /
1 ;
15 / .
24 , ,
C 4- 12- ( ). , - C 10/.

48 : 12 (, ),
36 .
,
C 1000 / 4
12 . ,
.
, 48- ,
, 24-
36- C.

C.
C, 1,
, .
, ( ). ,
C,
.

.

( ), (
),
.

, C 100 / 12
24 .
39



, C 1000 /
4- 12- .
.
.
, 1
, , , , ( , ,
). ,
, , .

1 Bacon B.R., Gordon S.C., Lawitz E. et al. HCV RESPOND-2 final results: high sustained
virologic response among genotype 1 previous nonresponders and relapsers to peginterferon/ribavirin
when retreated with boceprevir plus PegIntron (peginterferon alfa-2b) ribavirin // Hepatology. 2010.
52(suppl) . 430A.
2 Manns M.P., McHutchison J.G., Gordon S.C. et al. Peginterferon alfa-2b plus ribavirin
compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised
trial // Lancet. 2001. 358. . 958965.
3 Fried M.W., Shiffman M.L., Reddy K.R. et al. Peginterferon alfa-2a plus ribavirin for chronic
hepatitis C virus infection // N. Engl. J. Med. 2002. 347. . 975982.
4 Hadziyannis S.J., Sette H.Jr., Morgan T.R. et al.; for PEGASYS International Study Group.
Peginterferonalpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of
treatment duration and ribavirin dose // Ann. Intern. Med. 2004. 140. . 346355.
5 Veldt B.J., Heathcote E.J., Wedemeyer H. et al. Sustained virologic response and clinical
outcomes in patients with chronic hepatitis C and advanced fibrosis // Ann. Intern. Med.
2007. 147. . 677684.
6 Bruno S., Crosignani A., Facciotto C. et al. Sustained virologic response prevents the
development of esophageal varices in Hepatology, Vol. 54, No. 4, 2011 GHANY ET AL. 1443
compensated, Child-Pugh class A hepatitis C virus-induced cirrhosis. A 12-year prospective follow-up
study // Hepatology. 2010. 51. . 20692076.
7 Morgan T.R., Ghany M.G., Kim H.Y. et al. Outcome of sustained virological responders with
histologically advanced chronic hepatitis C. //Hepatology.- 2010. 52. . 833844.
8 Kwo P.Y., Lawitz E.J., McCone J., Schiff E.R. et al. Efficacy of boceprevir, an NS3 protease
inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with
genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial //
Lancet. 2010. 376. . 705716.
9 Poordad F., McCone J.Jr., Bacon B.R. et al., for SPRINT-, 2 Investigators. Boceprevir for
untreated chronic HCV genotype 1 infection // N. Engl. J. Med. 2011. 364. . 11951206.
10 Bacon B.R., Gordon S.C., Lawitz E. et al., for HCV RESPOND-2 Investigators. Boceprevir
for previously treated chronic HCV genotype 1 infection // N. Engl. J. Med. 2011. 364. . 1207
1217.
11 McHutchison J.G., Everson G.T., Gordon S.C. et al., for PROVE,1 Study Team. Telaprevir
with peginterferon and ribavirin for chronic HCV genotype 1 infection // N. Engl. J. Med. 2009.
360. . 18271838.
40

12 Hezode C., Forestier N., Dusheiko G. et al.; for PROVE, 2 Study Team. Telaprevir and
peginterferon with or without ribavirin for chronic HCV infection // N. Engl. J. Med. 2009.
360. . 18391850.
13 Jacobson I.M., McHutchison J.G., Dusheiko G. et al. Telaprevir for previously untreated
chronic hepatitis C virus infection // N. Engl. J. Med. 2011. 364. . 24052416.
14 Zeuzem S., Andreone P., Pol S. et al. Telaprevir for retreatment of HCV infection // N. Engl. J.
Med. 2011. 364. . 24172428.
15 Thomas D.L., Thio C.L., Martin M.P. et al. Genetic variation in IL28B and spontaneous
clearance of hepatitis C virus // Nature. 2009. 461. . 798801.
16 (SVR) among poor interferon (IFN) responders when boceprevir (BOC) is added to
peginterferon alfa-2b/ribavirin (PR) // Hepatology. 2011. 54 (Suppl.). . 376A.
17 Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the
American Association for the Study of Liver Diseases // Hepatology. 2011. Vol, 54, No. 4. . 1433
1444.
18 Sarrazin C., Hezode C., Zeuzem S. et al. Antiviral strategies in hepatitis C virus infection //
Journal of Hepatology. 2012. . 88100.
19 Sherman K.E. et al. Response-guided telaprevir combination treatment for hepatitis C virus infection
// N Engl J Med. 2011. 365. . 101424. Erratum in: N. Engl. J. Med. 2011. 365. . 1551.
20 . . 4 2013
242/10/21380.
21 Foster G.R., Hezode C., Bronowicki J.P. et al. Activity of telaprevir alone or in combination
with peginterferon alfa-2a and ribavirin in treatment nave genotype 2 and 3 hepatitis C patients: interim
results of study C209 // J Hepatol . 2009. 50 (suppl 1). S. 22.
22 Silva M., Kasserra C., Gupta S. et al. Antiviral activity of boceprevir monotherapy in treatmentnaive subjects with chronic hepatitis C genotype 2/3 // Hepatol Int. 2011. . 5. . 3558.

.. , . , . ,
. , . , .


1 HCV
, , 1 ( ) .
Summary
G.N. Isinova, E.Zhandosov, G. Akhzhigitova,
A. Akimova, M. Dlimbetova, B. Ulan
Protease inhibitors in patients with chronic hepatitis C,
caused by genotype 1 virus
The review article is devoted to the triple therapy of chronic infection with genotype 1 HCV,
are published data on the use of protease inhibitors (telaprevir and boceprevir) in combination with
pegylated interferon and ribavirin for the treatment of patients with genotype 1.

41

 16-008.616.61-002.3

2013, 5 (113)

.. , .. , .. ,
.. , .. , ..
- . .. ,
-, .

.
(, , , , , , .)
.
: , (), , , , .
- , -
[1, 2, 3, 4].
1 34
1000 ( 10 3040%).
56%. 2030% , 6 [1, 3, 4, 5].
.. (2007 .), 7,327,5
1000, 0,821,46 1000 [2]. , ,
[1, 3, 4, 5].

(, , , , , , .)
.

43 , , .
57 2025 ,

, . : 23 , ;
(1112 ) , ,
. 22 ,
.
()
42

. 34 ( 19 52
); 39 ( 18 59 ). 57 , , , ,
, , , , , , , , , . .
-:
,
[1, 2, 3, 4, 5, 7, 8, 15].
, ,
.
: (. . ) [1, 2, 3, 4].

: ( ), (, ), . [4, 5, 6, 7, 8].
, , , , .
, , , ,
, , ,
. , , , , , .
2000 .
, , . ,
- ; , , , .
.
, , . ,
. , , , , .
,
. 20 , .

, [6, 7, 9, 10, 11].
,
, (, , ) (,
, ) , [5, 8, 9, 12].
,
43

. , (, , , , , ,
, , .), , , [1, 3].
- , (,
, , ), - , ,
, . [1, 2, 4].
23 ,
, , , , .
, , [1,
2, 3, 4, 9, 10]. ( ), , , , , , , ,
; ,
: , , , , ). ,
[1, 4, 5, 8, 9, 10, 13]. ,
: , , , , [1, 5, 7, 8, 9, 10, 12, 14].
: , , , , , , .
: , , , , , , , , , , , [7, 10, 12, 14].



.
(-, )
2%;
(- ) 3% (. 1).
(. 2). 12%
[15].
, .
1

-,
25%, 23%

2%, 2%

>0,01
44

-


-, (57 /)
20%, 22%
>0,01

49%, 51%

-,
18%,19%

37%, 40%

>0,05

, (57 /)
17%, 18%

35%, 37%

>0,05

1. 1/5 (20%)
(-, ) (-, 57
/.).
2. , , , 1112 ;
3. , ;
4. 1012%
.

1 .. / .
: 2008. .2. . 546549.
2 / .. [ ]. . .: -,
2007. . 415.
3 .. [ ]. / . .: , 1995. . 2.
. 109141.
4 .. [ ]. . .: , 2000. .152.
5 .. . ., 1998. . 137152.
6 .. . . ., 1998.
. 116136; 339348; 448451.
7 .. . ., 1999 72 .
8 .. / - / . .., .. ., 2008. . 4451.
9 .., .. . ., 2009. 74 .
10 . / . . 2003 N 5. . 2731.
11 .. [ ]. . .: ,
1992. . 1823; 3033; 5861; 6772; 7579; 143145; 177180; 194199; 203206; 208214;
218225; 240242; 265270; 276278; 290293; 306316; 323325; 346359; 365372; 391401.
12 .., .. . .: , 1984.
. 212268.
13 .. : . .. . 1991. 33 .
14 ., . . , 1982. . 1315; 2527;
3032; 3946; 5461; 8895; 99; 107117; 123129; 131; 155; 170171.
15 .
45


.. , .. , .. ,
.. , .. , ..


, 2030%. ,
,
.
Summary
K.A. Sartayeva, B.A. Kuttykozhav, Zh.M. Rsalieva,
H.M. Muminova, K.M. Alshynbaeva, G.I. Cyzdykova
Importance of phytopreparations
in chronic pyelonephritis treatment
A high incidence of chronic pyelonephritis (2030%) is registered among the population
and particularly among the women of fertile age. Based on the examination results an incomplete
urinary tracts sanation is observed after conducting the first stage of anti-inflammatory treatment that
is manifested by asymptomatic bacteriuria and leukocyturia and preservation of residual effects of
dysuric syndrome that makes it necessary to conduct a long-term anti-relapse treatment course taking
phytopreparations.

2013, 5 (113)

616.61-002

.. , .. , .. , .. ,
.. , .. , .. , ..
. .. , .

. .
: , , .
. ,
() .
, , . ,
.
,

.
46

 . 10 (5 5 ) ,
. 30 60
( 489,1).
1 9 ( 3,5+0,8 ).
: 5 , 3 , 1 , 1 . 3
200 8
550 4 .
F6 .
3,7+0,9 .
-. :
1
Q

QRS

QT

0,20

0,08

0,42

64

0,18

0,08

0,38

74

0,20

0,08

0,38

67

777

0,20

0,10

0,36

80

. Q

0,16

0,08

0,38

63

0,16

0,08

0,46

75

0,18

0,06

0,36

76

0,16

0,06

0,42

75

0,20

0,08

0,44

73

0,20

0,10

0,40

65

2
Q

QRS

QT

0,12

0,06

0,42

78

0,16

0,08

0,44

68

0,16

0,08

0,42

92

0,16

0,04

0,44

90

0,16

0,08

0,44

78

0,20

0,08

0,46

62

0,20

0,08

0,46

85

0,20

0,06

0,40

70

. Q

0,20

0,08

0,44

73

0,18

0,06

0,42

82

47

 3
PQ

0,184

QRS

0,077 ce

QT

0,40

71 1

4
PQ

0,171

QRS

0,071 ce

QT

0,46

78 1

, , ,
, , .
5

(.)

,
/

,
/

Na, /

K, /

745320

28,19,5

135134

5,04.5

2,22,1

720290

27,69,2

139135

6,35,8

1,91,9

743321

30,110,2

141139

6,56,0

2,32,2

694294

28,29,3

136135

5,95,6

1,91,9

746364

27,39.4

136136

6,25,6

2,12,0

753, 326

30,69,9

139134

6,55,9

1,91,8

736330

29,310,3

142139

6,35,9

2,02,0

706288

30,29,5

136135

5,95,3

1,92,0

744322

33,29,9

132133

6,35,3

2,12,1

10

698274

27,89,2

137135

5,85,5

2,02,0

.
60%, 40%,
10%, 70%. , - . 15.
. 5,
(, , ), .
, Q QRS , Q
, ,
.
, - , , ,
. ,
48

 , , , , , , .
:
1. ,
.
2. , - , , , , .
3. ,
, .

.. , .. , .. , .. ,
.. , .. , .. , ..
,

, , .
Summary
G.I. Ryspaev, S.A. Kabduldanov, A.M. Kurmantay, A.T. Darmentayeva,
K.S. Nurmanova, S.N. Isakova, M.D. Sadyhanova, A.J. Botabekova
Electrocardiograms patterns of patients suffering from
The Chronical Renal Impairment in a terminal stage living
in Almaty region
The Presentations Results of Research Variations with patients occuring in a terminal stage
before and after Haemodialysis using Electrocardiograms fluctuations.

615.33.:616.64

2013, 5 (113)
..

- . ..
, .

: .
: , , .
, , ,
. 49

, . , ,
[1].
- , C. Trachomatis,

. ,
,
. , : ,
, , .

C. Trachomatis.
[2].
, . , .
. : ( ) ( ).
, .
. .
, ,
. ,
, ,
.

.
[3].
. ,
,
.
.
, 4- . C. Trachomatis
, . .
- .

27 (10 17 ) 24 35 ,
.
10 .
17 , 1 . 50

 , , .
500 1 10 .

25 (89,3%) . 4 , ,

. .
24 3
,
C. Trachomatis .
, ,
.
:
1.
, , .
2. , ,
.
3.
.

1 .., .. / . . 4. / . . .. . : . 1996. . 219262.
2 .. . 2002. 1. . 48.
3 .., .. / .
.. . ., 1998. . 111148.

..


. 27 (17
10 ) .
Summary
A.M. Ospanova
Experience with the drug "Remedy" in the treatment
of urogenital chlamydiosis
The paper shows the authors experience in treating 27 (17 males and 10 females) patients with
chronic urogenital chlamydial infection by using Remedy. The studies have demonstrated that
remedia is an effective antichlamydial agent that is effective in treating patients with chronic and
therapy -resistant urogenital chlamydial infection.
51

 616-007.2

2013, 5 (113)

.. , .. , .. , ..
. .. , .

.
. . , ,
.
: ,
, 3D-.
() 33,5%
10% [1]. 0,9 % 0,5%
[2]. .

[3]. , [4]. ,
, , 7%
, 14% .

, , . . 2040%
- .
()
,
.
, , [5].
H.A. (1998), ,
.
.

, , , () [6].
,
.
52

 ,
, . ,
, . () .
[7].
, , .
() ; . ,
, .
[8].
.
:
1. .
2. .
3. .

. .. 2013 .
2013 . 33 20 55 . 10 (30,3%), 23 (69,7%).

: , , . AQUILLION 16 TOSHIBA
Vitrea. ,
-
, .
( ) .
, .
.
:
() .
, , (Medrad) 3 /.
.
53

 300 370
/ (, ) 80100 .
() . 100
160 , . . ,
.
2 . ,
. , .
, , , .
() . 250400
.
. : . .
, .
.
( ) ( 15 . ) .
.
.
.
. 58 . .
, . ,
; .




.

L-
S-

54

21,2

2
1
1
3
5
3
2
9
33

6,1
3
3
9,1
15,1
9,1
6,1
27,3
100

 33 . , 7 , (21,2%), L- 2
(6,1%), S- 1 (3%), 1 (3%),
3 (9,1%), 5 (15,1%), 3 (9,1%), 2
(6,1%), 9 (27,3%).
. 11 .

.
, ,
, : , ,
. ,
.
- ,
.
, ,
, ,
() . .
,
, , , ,
.
.
.
, :
, , .
, ,
.

, - ,
.
55


1. .. : / . ,
.. , .. [ .] // . 2001. 4. . 711.
2. .. / .. , .. , A.B. [ .] // .
1- . . . . 2002. 1. . 1921.
3. A.B. 200 // . 2004. 1. . 8083.
4. .. // . 2002, N 6. . 4346.
5. .. / . .
1 : . 2- Me . ., 2003. .
2. . 7377, 57.
6. .. : ... . . . ., 2004. 142 .
7. .. // . 2004. . 49. 3. . 6369.
8. Coll D.M. 3-dimensional volume rendered computerized tomography tor preoperative
evaluation and intraoperative treatment of patients undergoing nephron-sparing surgery! D.M. Coll,
R.Gl. Uzzot B.R., Hertz et al. // J. UroL 1999, Vol. 161, 4. P. 10971102.

.. , .. , .. , ..


33,5% , 10% . ..
20 55
33 .
.
, .
Summary
M.K. Alchinbaev, N.M. Kadyrbekov, A.K. Buirashev, A.A. Muravyov
APPLICATION OF MULTISLICE COMPUTED TOMOGRAPHY PATHOLOGY
UPPER URINARY TRACT
Anomalies of the kidney occur in 33,5% of patients with urological clinics and up to 10% of
all the vices of the formation of the genitourinary system. On the basis of SC Urology named after BU
Dzharbussynov surveyed 33 patients with abnormalities of the upper urinary tract in age from 20 to 55
years. Multislice computed tomography method provides a three-dimensional images of high quality.
Multidetector computed tomography a highly informative, minimally invasive method of diagnosis,
which occupies a leading position in the algorithm of investigation of patients with abnormal kidney
development.

56

 616-006.3

2013, 5 (113)

.. , .. , .. , ..
. .. , .

. .
: , , .

6- 12-
,
[1]. ,
- , , ,
.
, , - 1993 2003 . 55%,
40 [2].
.

.
, ,
.
, , , , .
, , [3]. .
. , .
, - ,
[4]. .
,
, , ,
57

 .

.

, , .
-
,
, , , [5]. ,
, ,
,
.

.

. .. 2012- 2013 . 6 .

4, 2. 54,2 .

: , , . AQUILLION 16 TOSHIBA
Vitrea.
( ) .
, .
.
:
() .
, , (Medrad) 3 /.
.
300370
/ (, ) 80100 .
() .
100160 , . . , .
2 .
, .
58

 , . , , ,
.
() . 250400
.
. : . .
, .
.
( ) ( 15 . ) .
.
.
.

.
58 .
.


.. 48 27.02.2012 (/ 796/146)
, .

33,622,3 ( 1).

1.

, 2,82,3 ( 2 3).
59

 2.

3.

. ( 4 5).

4.

5.

01.03.2012 .
, , .
. 6- .
,
( 6 7).

6 7. - . 7- .
60

 871/875: - (- ). 3 .
, .
.
, ,
,
: , R-, .
, , . , - ,
.

1. .. - - // , 2009. 4. . 6167.
2. .., .., .. .
// .
2008. 3. . 39.
3. ..
// . 2009. 4. . 6774.
4. Patard J.-J. With increasing minimally invasive options for small renal timorous, it is time to
develop patient specific treatment strategies // Eur. Urol. 2007. 51. . 876878.
5. .., .., .. . -
// . 2009. 3. . 4248.

.. , .. , .. , ..


6- ,
12- ,
. ..
20122013 6 .
.
Summary
M.K. Alchinbaev, N.M. Kadyrbekov, A.K. Buirashev, A.A. Muravyov
MULTISLICE COMPUTED TOMOGRAPHY IN RENAL TUMORS
Among all cancer kidney cancer in frequency is the 6th place in men and 12th in women, and
timely diagnosis and treatment remain a major problem oncology. On the basis of SC Urology named
after BU Dzharbussynov for the period from 2012 to 2013, was conducted the survey and treatment of
6 patients with renal tumors. All patients underwent multislice computed tomography of kidneys with
bolus boost.
61

 616.67.3

2013, 5 (113)

.. , .. , .. , ..
. .. , .


. .
: , , , .
.
, (), ,
, ()
( ) .
,
( .., 2009; ..,
1999; .., 2007; .., 2008). 85%
10 45 ( .. ., 1985; .., 1988;
.. ., 1989; .., 2001; A.A., 2009).

4,610,2% ( .., 1988; .., 2001; A.A., 2004; .., 2007), .. . (1985), 25%
.
(..
, 2002).
1,0 2001 1,4 100 000
2006.
0,9 1998 100 000 1,2 2008 .
0,53% , 2539

(, 2009).
, , .
,
. .
( .., 2001).

() .
62

 . ,
() . 28 . , , .
. .

, .

.

108 . .. 2013
. 33,27,8 .
, .
Logiq p6 General
Electric , 1013 .
.
, ,
. .

,
.
, .
. .

.
1

34

32

41

38

33

30

108

100

108 78
(73%) .
78 , .
63

, 100%
, ,
.

3- : ,
.
.
2

24

73

30

97

31

98

33

100

, 31
, 30 .
.
()
, ,
(PPV).
, 3.
3 , ,
PPV

c ( )

= a/( a + c) (1)
= d/( b + d) (2)
= (a + d)/(a + b + c + d) (3)
(PPV) = a/( a + b) (4)
4

,
%

, %

, %

, %

75

66

71

79

0,005

91*

84

88*

83

0,003

94**

92**

91**

90**

0,002

* <0,005; **
<0,002.
64

 ,
. ,
, , 75%,
66%.
, , , .

.. , .. , .. , ..



. - .
108 .

.
Summary
M.K. Alchinbaev, N.M. Kadyrbekov, A.K. Buirashev, A.A. Muravyov
OPPORTUNITIES ELASTOGRAPHY DIFFERENTIAL DIAGNOSIS
OF SCROTAL ORGANS
One of the most common urological abnormalities in men are the various diseases of the scrotum.
Elastography a new word in the technology of ultrasound imaging. The basis of our work were the
results of a survey of 108 patients with various diseases of the scrotum. The use of elastography with
high accuracy to diagnose cancer processes of the scrotum.

616.643-002-073.756.8

2013, 5 (113)

.. , .. , .. , ..
. ..

: ,
, ,
, .
: , , .

, , [12].
65

 (
), .
() ,

[3]. ,
, .
,
, , , [46].
, . ,
.
2009 . . ..
. 15
. Toshiba.
18 61 .
20,0
, . ,
. , . . Vitrea.
3D- ( ) .
, , ,

.
15 . 3D- , . ( ,
) ,
, , ( 1).
1

0,51,0
1,01,5
2,0

66

2
2
11

4
6
4
1

%
13
13
74
27
40
27
6

 1
1

2

8
7
15

3
53
47
100

, 15
4
-
.
. 6
, -
. 3
, , .
, ,
.

:
1) , ;
2) ;
3) ,
;
4) ;
5) ;
6) ;
7) ;
8) .
, , , ,
.
,
, .
.
.

1. .., .., .. .
// . 2001. 5. . 2326.
3. .., .., .. . //
. 2001. 1. . 98104.
67

4. .., .. - // . 1997. 3. . 1619.

5. Meduri S., De Petri T., Modesto A., Moretti C.A., Multislice C.T. echnical principles and
clinical applications // Radiol. Med. 2002. V. 103, 3. P. 143157.
6. Zantl N., Beer A., van Randenborgh H., Hartung R. Virtual endoscopy of the urinary tract //
Urologe. A., 2002. V. 41, 6. P. 552558.

.. , .. , .. , ..


,
,
. 2009 ..
, 15 . ,
, ,
,
.
,
,
.
Summary
N.M. Kadyrbekov, M.K. Alhinbaev, A.K. Buirashev, A.A. Muravyov
The possibilities of MCT in the diagnosis
of urethral stricture
In recent years, to study the urethra widely used ultrasound voiding cystic cystourethroscope,
echourodynamic study, Doppler ultrasonography and three-dimensional ultrasound visualization
of the urethra. In 2009, on the basis of SC Urology them. B.U. Dzharbussynova developed a new
diagnostic method for imaging the urethra a virtual ureteroscopy. Virtual ureteroscopy performed
in 15 patients with urethral stricture. Analysis of the results allowed all patients to clarify the
diagnosis, localize the disease process, to assess the extent of contraction and the deformation of
the urethra, and the condition of the surrounding tissue. Application of a new method of diagnosis,
which is a virtual ureteroscopy, clarifies the peculiarities of a number of diseases of urethra,
deepening and broadening our understanding of the disease, thereby contributing to its successful
treatment.

68

 616.54-006-008.41:641

2013, 5 (113)

.. , .. , .. , ..
. .. , .

:

. .
,
.
: , .

,
[1]. , 52%
40 70 [2].
5070%
,
[3, 4, 5, 6].
, . ,
[7, 8]. , ,
( 2/3) , [9].
. ,
,

[10, 11].


. ,
[12].
, . .
69


.. 55 48 72 , , , .
Siemes G60 7,5 . .

,
. .
1040 1.
.
-.

.
.
1,30,27 4,70,9 / .
3060 3,21,24
28,47,3 / (p<0,01).
, ( 10 ) .
3,90,81 42,510,3 / (<0,01).
.
51 , . 6 5,
11
1.
4
: .
1
.

.
.

. ,
, , ,
70

 .

. ,
, .
, .

,
.

1 NIH Consensus Development Panel on Impotence. Impotence // JAMA. 1993; Vol. 270.
. 8390.
2 Melman A., Gingell J.S. The epidemiology and pathophysiology of erectile disfuction // J. Urol.
1999. Vol. 161. . 511.
3 ., . . .,1985. 246 .
4 ..
. . ... . . . ., 1993. 155 .
5 .. . .: , 1998. . 602622.
6 Meuleman E., Broderick G., Meng Tan H., Montorsi F., Sharlip I., Vardi Y. Clinical evalution
and the doctor-patient dialogue. In: Jardin A. Wagner G eds. 1st International Consultation on Erectile
Dysfunction. Plymbridge Distributors Ltd. UK. 2000. . 117138.
7 Andersson K.E., Wagner G. Physiology of penile erection // Physiol Rev. 1995. Vol. 75.
. 191236.
8 Saenz de Tejada I., Gonzalez Cadavid N., Heaton J., Hedlund H., Nehra A., Pickard R.S.,
Simonsen U., Steers W. Anatomy, physiology and pathophysiology of erectile function. In: Jardin A.
Wagner G eds. 1st International Consultation on Erectile Dysfunction // Plymbridge Distributors Ltd.
UK. 2000. . 67102.
9 Lue T.F., Tanagho E.A. Physiology of erection and pharmacological management of impotence
// J. Urol. 1987. Vol. 137. . 829.
10 Paushter D.M., Robertson S., Hale J. et al. Venographic impotence: evaluation with color
flow Doppler // Radiology. 1990. Vol. 177. . 177.
11 Petrou S., Lewis R.W. Management of corporal venoocclusive dysfunction // Urol Int. 1992.
Vol. 49. . 48.
12 Chiou R.K., Pomeroy B.D., Chen W.S., Anderson J.C., Wobig R.K., Taylor R.J. Hemodynamic
patterns of pharmacologically induced erection: evaluation by color Doppler sonography // J Urol.
1998. Jan.159(1). . 10912.

.. , .. , .. , ..



.

. ,
.
71

Summary
A.K. Buirashev, N.M. Kadyrbekov, M.K. Alchinbaev, A.A. Muravyov
DOPPLER ULTRASOUND IN THE DIAGNOSIS OF ERECTILE DYSFUNCTION
In the study of patients in a state of relaxation of the penis vein visualization preprostatical plexus
was well achieved with a longitudinal scan. Our proposed method for diagnosis of erectile dysfunction
venocorporal based on the features of the anatomy of penile venous system. Echodopplerography with
pharmaceutical heavy preprostatical venous plexus is a new, effective and minimally invasive method
of diagnosis venocorporal erectile dysfunction.

2013, 5 (113)

616-089
..

. .. , .

-
. , 370
- .
: , , - ,
.
-
, ,
.

.

[1]. , 6597%
[2].
. , 370 .
. 340
- . 53,93
. 12 (3,2%), 358 (96,7%).
II ( ) 240 (64,8%), III 75 (20,2%),
IV 55 (14,8%). 310 (83,7%) , 60 (16,2%) . , , .
329 , 7 in situ
72

 . 8 , 27 , 5 .

15 45 .
. , [3, 4], , , . 23
. :
6 (2,0%),
. 5 (3 2 ).
. , .

1 .., .., .., ..
- -
// . 1996. 34. . 710.
2 .. . 1993. . 1418.
3 .. // . . . ., ., 1990. . 4245.
4 Menger M.D., Stainer D., Messmer K. // Amer. J. Physiol. 1992. Vol. 263, 6 (Pt2). P. 1982
1900.

..
-


.
- . (1)
, 65 97%
.
Summary
O.A. Sekerbayev
RESULTS RECONSTRUCTIVE OPERATIONS
IN THE FEMOROPOPLITEAL ZONE
Chronic occlusions of the femoral and popliteal arteries are one of the most common
cardiovascular diseases. Surgical correction of this disease still remains the problem is not resolved and
a full contradictory opinions (1). At present, many surgeons adhere to the active tactics in this category
of patients, 6597% of patients they can fully recover or significantly improve arterial blood flow in
the lower limbs (2).

73


2013, 5 (113)

617.3-08
..

- ,

-
:
-.
: , , .
,
. ,
, , ,
[1].
. ( ), ( ),
( ).
. ,
.
.
1) , .
2) , , ( ),
() ,
, , ( ) [3].
3) , , ,
, .
34 .
1 2. 34 , .
- . , ,
, , , , .
.
74

 , .
.
, ,
, ,
. .
.
. ,
, .
,
, , .
3- : , . .,
, .
.
1. , , .
2. , ,
, ,
.
3. ,
, . ,

geny recurvatum.
, . 1,52 80
50% (, 1978 .).
:
1. .
, . .
2. . , 5 5 .
34 .
3.
.
4. , . 10 .
5. retinaculum patellae lateralis/ .
.
,

.
75

 .
, 4 , . 1012- .
4 . 26 .
24 1 10 .
23 ,
. 34,5 .
, 34- .
.
-.

1 .. // . ., 1983. . 5357.
2 X. //
1984. 9. . 2536.
3 .. . . .,
2000. 350 .

..
-

1 10 , 24
23- .
34,5 .
Summary
A.Zh. Toksanbaiev
Experience of treatment of patellofemoral osteoarthritis
on Macbeth Bundy
Long-term results were evaluated in 24 people in a period of 1 year to 10 years. In 23 patients
with knee joint range of motion is full, pain limiting the load on the joint is not. Medium term disability
was 34,5 days.

76


2013, 5 (113)

581.19
.. , .. ,
.. , ..

.
, , , .
: , , , , , , .
, , , ,
, ,
[14]. , ,
,
, [5].
,
, [68],
, ,
[9]. ,
, , ,
.


(
- ).
1
70 . (), (), ()
(. 1).

, , (. 24):
1) ( 80, 90, 100 ).
2) ( 50, 60, 80 ).
3) ( 1000, 1500, 2000 ./.).
77

(%)

0,2510,07

0,1880,08

0,205 ,08

(%)

491,1

442,1

411,3

(/)

311,2

331,1

371,3

(/)

3,70,09

3,10,1

3,50,15

.
2 1

80

31

3,7

0,251

49

90

32

3,8

0,252

50

100

30

3,6

0,250

48

50

31

3,7

0,251

49

60

32

3,8

0,252

50

80

33

3,9

0,253

51

1000 ./.

31

3,7

0,251

49

1500 ./.

32

3,8

0,252

50

2000 ./.

33

3,9

0,253

51

3 2

80

33

3,1

0,188

44

90

34

3,2

0,189

45

100

32

3,0

0,187

43

50

33

3,1

0,188

44

60

34

3,2

0,189

45

80

35

3,3

0,190

46

1000 ./.

33

3,1

0,188

44

1500 ./.

34

3,2

0,189

45

2000 ./.

35

3,3

0,190

46

78

 4 3

80

37

3,5

0,205

41

90

38

3,6

0,206

42

100

36

3,4

0,204

40

50

37

3,5

0,205

41

60

38

3,6

0,206

41

80

39

3,7

0,207

43

1000 ./.

37

3,5

0,205

41

1500 ./.

38

3,6

0,206

42

2000 ./.

39

3,7

0,207

43

, , ,
. , 100 .
, : 90 , 1 . 80 , 2000 ./.

1 .., .. //
. 2004. 1. . 8492.
2 .., ..
// . 2005. 12. C. 2329.
3 .., .., .. .
.: Scientific Press, 2003. 215 .
4 Kelly D., Conway S., Aminov R. Commensal gut bacteria: mechanism of immune modulation //
Trends Immunol. 2005. 26. . 326333.
5 Wolvers D., Antoine J.M., Myllyluma E., Schrezenmeir J., Szajewska H., Rijkers G.T. Guidance
for substantiating the evidence for beneficial effects of probiotics: prevention and management of
infections by probiotics // J Nutr. 2010. 140 (3). . 698712.
6 .., .., .. .
. : , 2000, 232 .
7 .., .. :
// . 2000. 8. . 2022.
8 .., .., .. . // . 2001. 4. .102107.
9 .., .., ..
//
. 2000. 3. . 8691.
79


.. , .. , .. , ..


, ,
.
Summary
A.S. Sarsenov, A.A. Aldashev, V.V. Kilmaev, M.P. Ionina
Influence of various technological modes of processing
of medicinal vegetative raw materials on some indicators
of its chemical compound
It is shown the change in structure of vegetative raw materials of such indicators, as the watersoluble dry rest, water-soluble fiber, polisugars and bioflavonoids, depending on specifications on
reception of extracts.

2013, 5 (113)

581.19:663.1

.. , .. , .. , ..

. - , .
: , - ,
- , .
- (
) - ,
, / , ,
, [1, 2]. , , ,

,
, [3].
, ,
. 80

 , pH ,
() - [4, 5].


(- ).


(
- ).
1
. - , .

(. 13). , , . ( 15:100).
101
1010 . 101
1010 0,1 2 .
444 371 1 3. , 15 .
, 1 3
,
. 721
38+1 . ,
, , .
,
.

1 1 2

/
1.
2.
3.
4.
5.
6.
7.
8.
9.

1- 2- 3-
. + 0,1 1
106
106
106
106
7
7
7
. + 0,5 1
10
10
10
107
7
7
7
. + 1 1
10
10
10
107
8
8
8
. + 0,1 2
10
10
10
108
8
8
8
. + 0,5 2
10
10
10
108
7
7
7
. + 1 2
10
10
10
107
6
6
6
. + 0,1 1, 2 (1:1)
10
10
10
106
7
7
7
. + 0,5 1, 2 (1:1)
10
10
10
107
7
7
7
. + 1 1, 2 (1:1)
10
10
10
107
+

81

 2 1 2

1- 2- 3-

1.

. + 0,1 1

107

107

107

107

2.

. + 0,5 1

108

108

108

108

3.

. + 1 1

10

10

10

109

4.

. + 0,1 2

109

109

109

109

5.

. + 0,5 2

10

10

10

108

6.

. + 1 2

107

107

107

107

7.

. + 0,1 1, 2 (1:1)

10

10

10

107

8.

. + 0,5 1, 2 (1:1)

108

108

108

108

9.

. + 1 1, 2 (1:1)

107

107

107

107

3 1 2 -

1- 2- 3-

1.

. + 0,1 1

107

107

107

107

2.

. + 0,5 1

108

108

108

108

3.

. + 1 1

10

10

10

108

4.

. + 0,1 2

109

109

109

109

5.

. + 0,5 2

10

10

10

108

6.

. + 1 2

107

107

107

107

7.

. + 0,1 1, 2 (1:1)

107

107

107

107

8.

. + 0,5 1, 2 (1:1)

10

10

10

108

9.

. + 1 1, 2 (1:1)

107

107

107

107

, 2 0,1 0,5 ; 1
1 , 2 0,1 ; -
2 0,1 .
, , , , 2.

1 . .
91500.11.0004-2003, 231 09.06.2003.
2 .. // / . . .. . .: , 2005. . 272276.
3 .., .., .. // . . .
2004. 4. . 3943.
4 . ., . ., . . // . . 2009. 2. . 5457.
82

5. .., .. . 1 //
. 2004. 3. . 3134.

.. , .. , .. , ..


-
- .
Summary
A.S. Sarsenov, A.A. Aldashev, V.V. Kilmaev, M.P. Ionina
Influence of various extracts from vegetative raw materials
on growth of intestinal microflora
Influence of extracts from vegetative raw materials on growth and development bifido
and lactobacterium and their associations is investigated.

83



2013, 5 (113)

616-002.5-08(574.51)
..

, .

.
.
: , , .
( )
, .
2010 . ,
, 2011 . . 2012 .,

15,9%, 2010 . 22,5%,

(1, 3- .) 45,3 32,0% ( 1).
1 (20102012 .)

. ,

2010

1350

. ,

IV

/ (1,
3- .)

526

481

35,6%

218

45,3%

218

22,5%

38,9%

2011

1359

483

35,5%

457

33,6%

178

38,9%

178

18,3%

2012

1334

511

38,3%

481

36,0%

154

32,0%

154

15,9%

:
, , , .

.
:
25.04.2011 , 218 , ,
, ,
84


. 180 .
.
.
.
,
.
2010- 2012 . 1520 ,
71,4%, ( 2).
2 ( 20102012 .)

. ,

2010

526

270

51,3

2011

483

345

71,4%

2012

511

471

92,1%

1520

1086

71,4%

,
( 2).
: , (), (), , , , .

.
.
IV
, 2008, 2009 .
3 IV 2008 .
IV

07
IV

42

37

88,0% 2

4,7%

25

20

80%

/
1

10

10

100%

/
2

26

24

92,3% 1

3,8%

100%

38

30

78,9% 7

18,4%

143

121

84,6% 11 7,6%

3 7,1%
4 16%

92,8%

4%

80%

100%

0
100%

3,8%

96,1%
100%

7 4,8%

2,6%

97,3%

2,7%

92,3%
85

 2008 . 143
, , : 84,6%,
7,6%, 4,8%, 2,7%,
92,3% ( 3).
4 IV 2009 .

IV 07

IV

74

60

81,0% 5

64

49

76,5%

100%

/ 27
1

23

85,1% 1

/ 36
2

26

72,2%

6,7%

5,4%

5,4%

9,3%

14%

1,3% 87,8%
76,5%
100%

3,7%

11,1%

5,5%

45

35

77,7% 6

13,3% 3

248

194

78,2% 13

5,2%

88,8%
8

22,2%

72,2%

100%

100%
6,6%

18 7,2%

2,2%

22 8,8%

91,1%
1

0,4% 83,4%

2009 . 248
, , : 78,2%, 5,2%, 7,2%, 8,8%, 0,4%,
83,4% ( 4).
,
. , ,
, , .
5

2008

115

80,4%

20

13,9%

1,3%

2,0%

2009

184

74,1%

54

21,7%

1,2%

%
2,0%

1,6%

0,4%

2008 , 2009-
80,4 74,1%, - 13,9 21,7% ( 5).
.
( , , ) .
86

 ,
, 92,3 83,4%
2008- 2009 .
:
1. 2010 .
45,3 32,0%.
2.
, .
3. 2008 , 2009
80,4 74,1%, - 13,9 21,7% .

1 218 25.04.2011 .

29.10.2012 471 . .

..




.
Summary
G.I. Seralieva
The effectiveness of the treatment of multidrug resistance
in the Southern region of Almaty oblast
This article provides the results of treatment with multidrug-resistant tuberculosis in the Southern
region of the Almaty oblast.

614.4

2013, 5 (113)

.. , .. , ..
- -
,

- ,
20082012

. 20082012
.
: , , .
87

 . ,
, .
2 .
, 2 .
2223 .
10 .
.
, ,
. - .
.
.
- ,
.
.
2010 29 1113
20112015

: 100
2013 98,1- , 2015 94,7- .
: ,
20082012 .
: - 20082012
.
.
:
20082012
:
1 20082012
/

2008 .

2009 .

2010 .

2011 .

2012 .

33

26

23

20

18

100

144,1

104,2

108,2

95,0

85,0

100

143,4

105,6

95,7

86,1

76,8

100

125,5

105,5

95,3

86,6

81,7

2 20082012
/

2008 . 2009 . 2010 . 2011 .

2012 .

100

7,7

11,9

4,7

4,8

88

 3 20082012
/ 01 16

714

1517

2008 .

1824 2544 4554 5564

6

10

10

63>
1

2009 .

10

2010 .

13

2011 .

2012 .

24

44

26

4 20082012

2008 .

10

2009 .

13

2010 .

11

2011 .

2012 .

55

22

5 144,1 85,0
, 1,7 , 41% .
, 20082010 100
, 20112012
.
5
.
- 20082009
11,9- 2011 4,8- . , 2012 .

. 1824 , 2544
4554 ,
77,6 % . 17
, .

. ,
.
43,3
, .
5 77,5%,
22%- .
89

: 5
1,7 , 41%- .



.
,
. .
.

1 -
20082012 .
2 2012 12 - () -
33 .
3 - 2010 08 -
() - -
649 .
4 2007 21
1263 .
5 - 20112015
.

.. , .. , ..

-
20082012 .
, 5
1,7 , 41%. ,
- . . .
Summary
R.K. Murzhanova, B.Zh. Mukhambetzhanova, B.S. Murzhanov
Morbidity of tuberculosis among East Kazakhstan oblast Syrym area
population for 20082012
By the results of research in the Syrym area over the last 5 years morbidity of tuberculosis
decreased by 1,7 times or by 41%. These are the results of collaboration of the government and health
service organizations strengthening of promotion of a healthy lifestyle and high-quality carrying out
sanitary and educational work among the population.
At the same time, high morbidity among the unemployed and among persons with low level of
the income is noted. Guards tendency to infection with tuberculosis smong tecuagers.

90


2013, 5 (113)

614.3(574-51)
..

2012


.
2012 .
: , , ,
.


2012 001- 1686
, 1660- , 24- . 1450,
1431.
1638 , .
50
87,3%, 50- 250 8,3%, 250 3,4%
.

1 1638

- 2012 .

271

166

262

209

335

125

270 1638

149

57

129

128

165

58

133 819

122

109

133

81

170

67

137 819

46

26

11

16

18

126

23

36

18

15

32

85

12

21

19

14

20

101

55

35

59

44

90

14

56

353

41

32

77

-
. ,
2-
91

 . 12 ,
0% , 12 .
0,15% .
.

1,7%, 2,7% . 4,2% .
250- 24
20-, 74%- .

24 , 3 ,
27 .
14. 11 , 34,5%- 41%- .
7 , 100%
. 72810 3 . - 100%.
, , -

.
17.01.12 . 93-
- -
-

.
, .

- [1].
2 20072012

2007
2008

25

16

40

24

19

132

11

14

23

22

12

91

2009

19

10

57

2010

11

12

11

53

2011

10

29

2012

27

12,5

3,2

4,4

24

3,8

4,8

, 6
4,8 .

[2].
92

 1163 ,
72,4%, 27,5%.
3 :

28,6%

17,3%

15%

30%

18%

32%

42,4%

27,5%

, , .
112 , 9- ,
.
-
, , - -
25.01.2012 . 166 . 2012
.

1 . :
, 2009. 109 .
2 . . . ., . ., . ., . .

// . 2013. 1, . 178190.

..

-
.
- 2012 . 2012 .
Summary
B.A. Asylbekov
The volume of work performed for the control
of industrial enterprises of the State Sanitary
and Epidemiological Supervision of Zhetysu district of Almaty
This article presents the results of the work done in 2012 Zhetysu district. During 2012 all the
situation in the city was positive.

93


2013, 5 (113)

614.7:574:546.3-053.2
..

2012 .
: 2012
. 14
, 14 , - , - .
: , ,

- .
2012 :
;

30 16,1%.
12 2012 .
. , , , , , , , ,
, , , , , .
2,0 , 1,1 , 3,2 , 1,2, 1,1 .
1 ,
1,7 , 1,1 ,
1,1 , , 1,1 .
: .
. 3956
.
, . ,
,
.
100%.
94


[1].

. , .
.
,
2012 . 74 , 43,1%,
171442, 1,5%. ,
(34 .). , 2- 69
, 93,2%.
, ,
, 34-
(44,9%), .

.

6,0%.
12 2012 .
, 12 2012 440 , 30 ,
100 17,4%
,
- , .
, , .
.

. ,
.

. 21 , 100
12,2%. 19 (91,0%), 2 (9%).
4,26, 14
13,36. 85,7% .
57,1% 95

. 16,1%.
.
. -
.
.
2 . . , , .
100% .
.
14
, 14 , - , - . [1]

2012 91 , 100 52,4. 10 .

85,7%
, 38 (41,7%). 13 (14,2%).
14 2 , 5
.

. .
100%.
, 63,6% 0,5%, 13,6%.
.
,
42 , 46,1%, 8 , 8,9%,
9 , 15 , 16,4%.

1 . :
, 2009. 109 .

..


2012
. . .
96

Summary
.. Kalykova
Analysis of the management of state sanitary
epidemiological department
of Almaty by Medeu district for 2012.
This article provides information about the work by Medeu district for the 2012 year. Results of
analysis on the epidemiological situation is stable.

614.7:574:546.3-053.2

2013, 5 (113)
..

.
:
. .
: , , .

, , : , ,
, ,
.
, , ;

, ,
, , ,
. .;
, (
, ,
);
.
: , , , , , ,
.
. , ,
, .
97


,
.

, ,
- .
-
, , , , .
,
.
, . , .
,
, , (, ) , .
(, , ,
)
.

, .
.
( , - )

. (
.) -
, , -, . . , .
,
.
+,
(, , , ), , ,
.

, , ,
. 2009 79 221 000 .
98


.

, , , 2011 14 181 165 ,
263 120 , , ( 2012 .
113 788 378 . 268 174 . .).
, .

: ,
, 6 [1].

2011 14 181 165 , 2012 . 113 788 378 .
, ,
2011 : 1 693 812,4, 1 396 293,4,
270 032,0, 25 346,0, 2 141,0, .
2012 : 1 235 894 ,
868 896, 263 117, 96 654,3, 7 226,6, .

- (150 1 ), .
-
.
2011 1470,
. , ( , , ), 29, , - - (, ,
), 51, ,
, 325, 286, , , 16, -
3, 2, 758.
- - 14,
, , [2].
, , - , 98 (
), , 609.
6,
: ,
, , , , .
99


1 - , ,
, , .
: , 2004. . 105.
2 . :
, 2009. 109 .

..

.

.
Summary
G.K. Kilibaeva
On waste management of medical organizations
To waste, depending on their risk class, have different requirements for the collection, temporary
storage and transportation. The mixing of different classes of waste at all stages of gathering, storing
and transporting are prohibited.

614.7:574:546.3 053.2

2013, 5 (113)

.. , .. , .. ,
.. , ..
.. , .

:
.
: , , .
-

-
. ,
: ,
20092018
, 20112020
.

. , , - . , ,
,
.
100


52 26.05.2000 .
, 20092018

.


.
20112012 , 768 , 251 32,68 % (2011 . 24732,16%) . -
: 1,044 . (2011 . 1,095,9 ), 1,31,43
. (2011 . 1,161,66 ), 1,12,5 , 1,012,0
(2011 . 1,012,06 ), 2011 1,081,42 .
32,68%, 2011 (32,68%- 32,16%-).
2012
. ,
52 (2011 50). 2012 2 : ,
. 52 3 ( , -, -1). ,
.
.

. 8
, 8. 932 , 48- - , 5,15% (2011 780
232,94%) . 2011 2,21%
(5,15%- 2012 2,94% 2011 ). 18 ,
6 1- 2- : , ,
, , , .

2,324,68 , 1,141,65 , 1,231,53
- .
2012
,
- 16180
-, 3236 (
2011 1 ), 1 ( 20110) .
219 , 47- ,
21,5% . :
, - , .



.
101


1 .. . ., 2003. 190 .
2 .. : . . . . , 2008. 221 .
3 , . . 1. 10.1920.04. ., 2004. 170 .

.. , .. , .. ,
.. , ..



. ,
.
Summary
N.Zh. Dogalbaev, D.M. Baitilesova, A.D. Iliyasova,
K.A. Baykenzheeva, N.N. Aytambaeva
Conducting health surveillance of air quality
According to the annual plan for the year in the city on the main streets of the main city every
quarter is conducted laboratory monitoring of the air basin, and residential areas in the vicinity of
industrial plants once a quarter.

614.7:616-053.2

2013, 5 (113)

.. , .. ,
.. , ..
.. ,
- ,
.

:
.
: , , , .

2009 18
( ,
, ) .
,
.
102


.
. .
:

( ), 5
. 3132, 34, 41, 13 /, -90
, .
450 ,
40%- .
( ) , 10
, 6 . 7800
.. 2840 .
26, 6 . 14 ,
3, 11.
, (2009 81, 2010 79, 2011 60),
11 14
. 20092011. ,
2012 . .
.
1
:

2009

330

0,3

2010

343

2,3

2011

292

0,3

-
. , 3040 ,
40% .
,
.
, . [1]
2

2009

17

2010

17

2011

18

: 2009 . 3, 2010 . 4,
2011 . 4.
,
( /30) -
103

 , .
-, -, , , , .
, .
3

2009

82/44

53,6

2010

91/91

100

2011

94/89

94,6

,
, -
[2]. 01
/30 . ,
, , - . 2011

.
(2012 1/3
, )
.
:
1 . .
. , 2010. 75 .
2 :
, 2009. 109 .

.. , .. ,
.. , ..
-
-

.
Summary
G.A. Kudaibergenova, G.B. Elgondina,
L.N. Aitambaeva, A.D. Kuttbaev
SANITARY CONDITION OF ECONOMIC-DRINKING WATER SOURSE
AND PLACES OF CULTURAL AND COMMUNITY WATER USE
IN TURKSIB AREA OF ALMATY CITY
In the article presented the organization of the control over drinking water supply and the open
reservoirs of Turksib area in Almaty city.

104


2013, 5 (113)
614.7:616-053.2
.. , .. , .. ,
.. , ..
. . ,
-
, .

,

. , - .
: , , .

. , , . , , , ,
. .
.

, , .
. ,
- [1].
2009 2011
, : 260 , 45; 300
, 220; 200
20.
, . , 2- ,
() , 4 , 9 , 4 , 19
.

500 ,
360 -,
-1 . , - .
, , -
,

,
.
105

 1 -

2009

38

38

2010

32

12

19

2011

46

30

-
, .

[2].

, -
.

, - 28 2010 299 33
,
. , ,
-
-

. -
.
2

2009

2010

2011

217

255

196

269

79

118

49/18

76/54

22/18

142

129

120

25

20

32

97

94

75

. ,
. 2009 13 , 2010 . 9
, 2011. 6 , 2012 . 6 .
106

 3 - .
.
2009

2010

2011
4

38

14

:
1 . .
, , 2010. 75 .
2 :
, 2009. 109 .

.. , .. , .. ,
.. , ..


.
Summary
I.V. Ten, A.D. Kuttbaev, L.N. Aitambaeva,
G.A. Kudaibergenova, G.B. Elgondina
SANITARY EPIDEMIOLOGICAL CONDITION OF THE MEDICAL ORGANIZATIONS IN
TURKSIB AREA OF ALMATY CITY
In this article presented data on positive dynamics in activity of municipal hygiene department
under the control over the medical organizations.

614.7:616-053.2

2013, 5 (113)

.. , .. , .. , ..
.. ,
-
, .

. ,
.
: , .
2004 24 137 -
, - ,
107

, , ,
-
. -
, , ,
. -
.
. , ,
. ,
.

[2].

. - , .
, , ,
, . , ,

2004 26 2674
2004 13 19
, , ,
-
. () ,
, , .
.
, -
.

. .
,
.
11 ,
2 ( ,
) 9 .

.

, . 2010
340 200 93 , 2011 598 752
56 [2].
108

2009

23

26

2010
2011

10
17

8
15

2011
.
2008 .
:
1 ..
. , 2010. 75 .
2 :
, 2009. 109 .

.. , .. , .. , ..



.
Summary
G.B. Elgondina, A.D. Kuttbaev, G.A. Kudaibergenova, L.N. Aitambaeva
SANITARY CLEARING AND THE ORGANIZATION OF HOUSEHOLD WASTE
EVACUATION IN TURKSIB AREA OF ALMATY CITY
In the article presented data on improvement of sanitary clearing and the organization of
household waste evacuation in Turksib area of Almaty city.

614.7:574:546.3-053.2

2013, 5 (113)

.. , .. , .. ,
. , . , .
.. , .

- -

.
.
: , ,
.
109

 -
, , - -
25.01.2012 . 166 - 2012
26238 20 26232-
(99,9%) (2011 . 99,3%).
-

.
- -
( )
,

.
- -

. - -

.
,

[1].

-
-
.

1 -
2012
.

- 100%
. 923 , 3,5%-
(2011 . 10,2%), 213- (23%) (2011 . 9,9%).
110

24,0%

6,7%

21,8%

6,4%

10,5%

10,2%

2012

4,1%

2,6%

3,1%

6,8%

4,8%

1,7%

3,5%

3,5%

3,0%

4,1%

2011

18,
0,06%, 0. 92
852 ,
(2011 . 61573 ) [2].
223 .
.
2 678 114 163 (2011 . 153 2 608 836 ), 147 . 47 (2011 . 8) .
:
;
;
;
;
;
- ;
.
100 , , , , .
- ,
-
.

1 . :
, 2009. 109 .
2 . : 166 : 25.01.2012.

.. , .. , .. ,
. , . , .


.
111

Summary
D.M. Baitilesova, K.A. Baikengeeva, A.D. Iliasova
M. Ziyabekov, N. Ezdibaev, A. Kydyrbaeva
Preliminary and periodic medical examinations of workers
in hazardous conditions
For employees working in hazardous occupations and work in harmful and hazardous production
factors for five or more years of regular medical examinations every five years, conducted in centers
Occupational and other health care organizations that have licenses for proficiency examination and an
examination of the disease due to the profession.

2013, 5 (113)

: 616 053.2:378.147/.150
..

8, .

.
, , 8 . .
, , .
: ,
.


, ,
.
, 11 1995 .
: ,
, .
,
:
,
, , ;
; ; ; ,
112

 , , , , ,
, .
.
, , [1].
,
, : , ,
, , , .
-,
[2].
2011
. - , . , (
), .
C , - .
- .

( ), ( , , , , , ), ( ),
( ).
.
:
,
;
.
, , ;
- ( , , , , , . .).

, ,
.
().
113

 , ,
, , .
.
,
(, ) , , , , , ,
. . : .
, , , ,
: , ,
, , , ,
. .
,
. .
,
. . 0 15 ;
.
,
,
, ,
, .
, , , , , .

1 // ,
, () .
2012. 41 .
2
, . 2005. 365 .

..


, 8
. ,
, .
114

Summary
A.A. Sadirova
WAYS OF INTRODUCTION OF THE INTEGRATED MAINTAINING PATIENTS
OF CHILDREN'S AGE IN THE PEDIATRIC SERVICE
This article describes ways to implement the integrated management of pediatric patients in the
pediatric service, in particular the city polyclinic 8 Almaty, with the training to health workers. The
use of training programs in the daily work of employees closer to the real professional work which is
objectively reflected in the activity of the medical staff at work, increase their level of qualification.

2013, 5 (113)

616.24.002.5-07-053(075.8)
..

.
( ). 5 9
.
: , , .
. 70
. ,
.
. , , ,
[1].

.
. ,
[2, 3]. ,
. 64
118 .
.
.
,
. , ,
115

 ,
[4, 5].

14 .

( ,
),
.
c,
.
, .
,
2- . 1 .
[6].
12 2012
2688 , 2659 (99%) , .
2012
M 19044 , 19 459 102%. 1136 (87,9%)
. 12 .
, 15511 , 46% . 2011 50% (16 597
), . . . , 1087 , 51
. 2011
1262 83 .
5 ( . -, . , . ,
. ) , ,
14,8 100 . . 5 4 (80%)
1 (20%) .
2012 (+) 97 (
2011 . 101), () 29 ( 2011 . 48).
(+) 189 (191 2011 .) () 42 (60 2011 ). .

2012 67,6 2011 (78,1 100 ).
2012 4971
, 95,4%. 25 , 5 (. , . , . , . . , . -)
, .
116

 (+) 21 () 6 .
. .
45 . 52 (2011 . 69). 12 77 (2011 . 54 ).
44 .
159 (2011 . 101) .
123 (2011 . 194 ),
11 (4 2011 .) .

, 100%-
,
, 100%- .

814 . , .
,
. ,
,
[7, 8].
:
. ,
. 59
.
.
, : 15 17 ,
15, 16 17 .

1 ..
: . . . . ., 1993.
2 .. (, ): . . .
. .,1998.
3 .. . ., 1975.
4 Expanded Programme on Immunization. // Global Advisory Group (1990). Part II. Wkly
Epidemiol. Rec., 1991. V. 66. . 912.
5 Iidirin I., Sapan N., Cavucsoglu B. Arch. Dis. Child. 1992. V. 67. . 8082.
6 Milstien J., Gibson J. Bull. Wid Hith Org. 1989. V. 68. . 93108.
7 Sirivanin S. et al. Pediatr. Infect.//Dis. J. 1991. V. 10. . 359365.
8 Smith D., Harding G. Document TRI/SCG/79.6.1. Geneva: WHO, 1979.
117


..



- . 59
.
Summary
B.Zh. Imankulova
Prevention and early detection of tuberculosis
in children and adolescents
This article is about the prevention and early detection of tuberculosis in children and adolescents
Almaty region, Panfilov district.In the group of 59 years, the main focuses are the massive diagnosis
of tuberculosis and improve the methods of detection of primary infection in children.

2013, 5 (113)

616-053.2
..

, .

-
. ,
.
: , , , .
, . - - ().
1,3 , 9
.
( ), (), - .
() (5 ) ,
. , , .
.
/ . -,

.
118


.
: ( , - ,
) , , .

.
(), ( ) .
(, , .),
(, ). , , . , , ,
. , , .
, .
.
, ,
. , ,
, [1].
. :
:
;
, ;
;
;
;
.
, :
;
/ ;
;
;
, , , .
;
;
;
.

:
; ; (2 ); .

/ , .
/ . , , .
119


.
, .
(, ) . , . ,
,
[2].
. .
. ,
, 23 .
.
,
.
, , , .
,
, .
.
(, ),
, ,
.
:
, ,
[1].

, . - .
.
, , , , . 6 . . , ,
, [1].
, .

1 E.., .. : // . 2003. 10. . 6571.
2 656 19 2008
.
120


..

,
.
Summary
T.Zh. Beknazarova
Diarrhea in the practice of the district pediatrician
This article presents a summary of the clinical diarrhea, results of treatment of this disease and
the most important dietary recommendations for sick child.

616.5-004.1

2013, 5 (113)

.. , .. , .. ,
.. , .. , ..
, .,
.. , .

c

.
.
: , , .
() , , -
.
, .
1 50 300
. ,
. 3050 [1].
:
, .
, : (), ( , ,
) [1].
,
[2].
,
.
, . .
121

 .
, .
.
. .
. I
IV , ,
, ,
. , , , .
5080%- [2].
, , , . , , .
,
.
-
70%-
[3]. , ,
.
.
- - ( ,
), ,
. ,
.
- ( ), .
,
, .
.
,
.
:
,
.

., , 32 , .
- :
, ,
, ,
, , . , ,
, , .
.
, 3

, .
, .
, .
122

 .
.
: , .
, . .
. .
, ,
.
.
,
.
. , [3].

1 Armando Gabrielli, M.D., Enrico V. Avvedimento, M.D., and Thomas Krieg MECHANISMS OF
DISEASE //The New England Journal of Medicine, M.D. N. Engl J. Med. 2009. 360. . 1989
2003.
2 .., ...( .). / . ., , 2008. . 1520.
3 .. . . . . , 2012.
www.rheumatolog.ru

.. , .. , .. ,
.. , .. , ..



.
.
Summary
F.K. Smailova, A.M. Myrzakhmetova, Zh.A. Zhabataeva,
A.M. Kalieva, A.S. Chimkentbayeva, A.M. Chynykulova
Clinical condition at diagnosis
of systemic sclerosis in the practice
This article presents a summary of systemic sclerosis and describes a clinical case of the disease.
According to recent reports, after adequate therapy the mortality rate dropped from scleroderma.

123


2013, 5 (113)

616.1

.. , .. , .. ,
.. ,.. , ..
..

. , . 25
.
: , , ,
.
: () - , , .
24,3% ,
(39%) (37%) .
19752007 . 2 , 2 (867,9
448,0100 ) [1].
2010 . /-
140/90 . . . ,
. :
130/85 . . . 125/75 . . . [1, 2].

, .
510% , -
5060% .
. (16
60%), ,
1 . ,

, , ,
[3].
: - ,
.
: 25 .
, , -, , , , ,
, - -, ,
.
.
: 2070 128 .
60 , 46,8% .
82,9% . 42,2% .
3070 ( 54
124

), 28 (51,8%), 26 (48,2%).
35,3%, 41,2%, 23,5% . 41% , 11,7%,
35,3%.
- 35% ,
18,5% .
, 47%, 35,5%,
47%.
65%, 40% . 47% , 29,4%. 53%
.
32,8% , , , , 14,2% .
. 67%
, 47% 28 , 20% 1 .
58,8% .
, , ,
.
.
:
.
, .
23 .
, - ,
,
. ,
.

1 //
. , 2009. . 1520.
2 ,
//
. 2000. 7.
3 .., ..
: . . ..
. ., http://medicina-online.ru.

.. , .. , .. ,
.. , .. , ..



, , . , 25 .
125

Summary
F.K. Smailova, B.S. Kalymbetova, A.E. Zhunusova,
M.S. Zamarhanova, I.S. Kaldarbekova, R.I. Kalekeeva
Using questionnaires to assess the arterial hypertension patients'
adherence to treatment
Given the estimation of public awareness of hypertension and its complications, treatment
adherence. For this aim developed a working questionnaire containing 25 questions.

616.1

2013, 5 (113)
.. , .. , .. ,
.. , .. , ..

. ..

. . , ,
, .
: , ,
, , .
, , (). ,
, ,
,
. (),
() .
, ()
, , .

[1].

( ),
(),
. ,
.
, . ,
, . ,
, [1, 2].
126

 : ,
. ,
. .
, .
, ,
( ).
.
,
, () ..
, ,

,
.
, ,
3060 . ( ).
, , .

(), . 24,9 /2,
, .
, .
, .
10% .
24,9 /2.
, 89 , 102 , .
() ,
, 6,5%.
, ,
. .
140/90 . . , . , , ,
,
, . b, ,
[3,4].
:
.
,
7% ;
127

 (
200 ).
10 , ,
2 , . .
,
. ,
( ) ,
. 2,5 /,
1,8 /. .
() 10 1 /.
10 80 .
. /. Walter 525 ,
38% 25,4% . ,
.
ARMYDA
. 153 (
), .
: (n=76) 7
, (n=77) . 6 24 .

, I, .
, 7
. , (
), : 12% 35%
, I 20% 48% ,
22% 51% .
, ,
.
. ,
,
.
(), .
, 75100 /., . ,
( , - ) .
()
. TAXUS IV
SIRIUS 325 /. 128

 ( 75 325 /.).

(160325 /.) (75100 /.) . , ,
. ACC/AHA/SCAI 2007 .,
, .
( 1 ., 3 ., 6 .)
162325 /. 75162 /
.
75162 /. .

, .
75 /. , , 12 .

.

(,
) . () 75
/. , , 1 ., 12 .
2 .
(

). , ,
.
2,02,5,
75 /. (, 1 ).
, , ,
,
. , ,
,
[5, 6].
: ,
.
. : , , , . ,
, .
.
129


1 .., .., .. :
// . 2011. . 16, 21. . 1419 1423.
2 Smith Jr., John W., Hirshfeld Jr., Alice K., Jacobs. Writing on Behalf of the 2005 Writing
Committee, ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention,
Practice Guidelines, 2007 Writing Group to Review New Evidence and Update the American College
of Cardiology/American Heart Association Task Force on Percutaneous Coronary Intervention // J.
Am. Coll. Cardiol. 2008. 51. P. 172209.
3 Mauri L., Normand SL. Studies of drugeluting stents: to each his own Circulation. 2008.
117. P. 1650.
4 Boden W.E., ORourke R.A., Teo K.K., et al. Optimal medical therapy with or without PCI for
stable coronary disease. //N. Engl J Med. 2007. 356. P. 1516.
5 Wong EML, Wu E.B., Chan C.M., et al. A review of the management of patients after
percutaneous coronary intervention. Int //J. Clin Pract. 2006. 60 P. 582589.
6 Fox K.M. EURopean Trial on Reduction of Cardiac Events with Perindopril in Stable Coronary
Artery Disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among
patients with stable coronary artery disease: randomised, doubleblind, placebo-controlled, multicentre
trial (the EUROPA study). 2003. 6. P. 362368.

.. , .. , .. ,
.. , .. , ..


, . - -
.
.
Summary
N.V. Abuova, F.A. Achabaeva, G.N. Aliakparova,
I.A. Goncharova, A.S. Musahanova, A.A. Hasangali
Management of patients after percutaneous coronary intervention
This article shows modern complex patients monitoring after coronarangiografy. Reflects
positive effect of medical treatment and domestic methods which provide wellness and upraises
positive effect.

2013, 5 (113)

616.24-002
..

. .. , .

- .
. - .
-23
.
: , - , , -23.
130

 () . 90% , 70%
- . .
7080% , 6% [1].
, , , .
.
, . (8090%) ,
10% .
2009 . /H1N1/ 04/09/,
, 11 2009 . : , 2009 .
440 . A/H1N1, 5,7 .
.
.
5 40 . , , , , - , ,
5 .
, .
:
. ,
- . 2045 .
. (13,7 .), (19,7 .), (2,1 .),
(2,4 .), (1,5 .), (1,4 .), (1,3 .),
(2,9 .), (1,1 .), (1,3 .), (1,1 .).
899, 666, 514, 264, 222, 178,
160, 133. /H1N1/09 [2].
, , , ( Streptococcus pneumoniae,
Haemophilus influenzae Staphylococcus aureus). ( ). , .
, .
,
34 . , , , , 131

 . ,
, , , , . - .
( ,
).
, . , , - , , . [3].

., 1992 . . - , ,
, , , ,
, .
: (25.01.13 .),
. . 31.01.13 ., , 60/40 . ., 104 ,
38,8 0, .
: ,
, , . ,
. . - . , . . . . ,
.
, . 28 .
. , . 120 . 60/40
. . , - . ,
. . .
. .
,
, . , ,
. . ,
58 /. : 120
1 . SI-SII-SIII. .
. ,
.
- . 19-
: 90 .
:
, , II. - II . .
.
. : 1,0 2 /,
6 /; 20 .
; 100 , ,
.

CURB-65,
45 : ( consciousness),
132

 >7 / (U urea), 30 . (R respiration), <90 . . <60 . . (B blood pressure),

65 . 1 . 2 .
PORT, CURB65
. , , ,
, , .
,
, .
, , . , 23 23-
, . 23
23
(1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10, 11, 12F, 14, 15, 17F, 18,19F,19,
20, 22F, 23F, F). 90% ,
.
23 , . 23 80% ,
, 92% ,
.

23 .
2 8- .
; 58
. (0,5 )
3 .
, () 23 1997 . 1820 -
,
. ( ) 0,5 100 ; , (0,5
0,95% ), 145 .,
. ,
5 . () 23 . .
, 4,8 6,1 lg/ ( 4,9 5,3 lg/). 5 .
5,9 lg/ ( 5,1 lg/) [4].

23 1,51 ,
2,05 , 1,37 . 25 2,24 ,
(22 72 ), 12,97 (1
19 ), 6,14 (2 18
133

). ,
55,36%, 92,29% 83,71%.
.
, .
:
2,1 , .
, 6,2 .

1 .., ..
/H1N1/09 // . 2011. . 26. . 2124.
2 .. . : , / . 2010. 25 .
3 .., .. // . 2006. . 14, 2. . 9094.
4 .., ..
// . 2003. 5. . 45.

..
- .
- .
23
.
Summary
M.N. Zainov
Viral and bacterial pneumonia. Clinical case
In this article describes a clinical case of viral and bacterial pneumonia. Propose Pneumo 23
vaccine formulation for the prevention of complications of the disease and reduce mortality.

616.5-001/-002-08

2013, 5 (113)

.. , .. , .. ,
.. ,..
. .. , .

.
() , .
: , , , .
134

 (-10, L20) , .
, , ,
.
(
1020% ),
. .
, .

(Ig) .
IgE IgE-. [14].

h1/h2-, , , . , (.14).

, .

2 Rajka

3 Rajka

, .
[57].

4 3
135

 :
, -
.
. ,
, ,
, .
(
).
, , .

. () 10
. .
() , . , , .
(. 46).
, 26 000 ,
7000 , , ,
,
, .
2 , ( , , ), ,
.
2 , 9 6 .

, . , .

1 .. , : . . . . ., 2008.
136

2 Bornhovd E. // J.Amer. Acad. Dermatol. 2011.

3 Bos J.D., Sillevis Smitt J.H. Atopic dermatitis // J European Acad. Dermatol.Veneriol, 2001.
4 Cooper K.D. New therapeutic approaches in atopic dermatitis // Clin Rev Allergy. 2010
5 ., ., . , 2010.
6 .. , 2009.
7 .., .. , 2012.

.. , .. , .. ,
.. , ..
() ( )
.
Summary
B.K. Kodanov, A.A. Kozhanova, M.B. Kusainova,
A.N. Kuralbayeva, T.T. Baimoldayeva
Ointment Tacrolimus in the treatment of atopic dermatitis
This article summarizes (the main symptoms and results) studies of ointment Tacrolimus
(Protopic) in the treatment of atopic dermatitis, which showed a positive effect.

2013, 5 (113)

616-085:615
..

, .

. .
.
.
: , , .
,
,
.
()
, . . .
.
, .
. , 137

 (, , ). , 2 3
5 [1, 2] .
,
, . 1020%.
. , , ,
[3, 5].
. . .

. , , ,
, . , ,
, , [4, 6].
- , , 2012 350, 2011
200, 100 2011 220 2012 .
, ,
, .

.
( ) , , .
.
45 , . 510 10, 10 20
, 15. 40% , 25% (
), 45% , 30% .
, , , .

, , .
35- . 8- , , .
138

: , , , .

, .
,
, .

1 .. : - . .,
2002. 200 .
2 .., .., .. // . 1997. 6. 206 .
3 .., .. . : , 2003. C. 238.
4 .., .. // . .
. 2002. 3. C. 2830.
5 .., .. // . 2000. 3. C. 6163.
6 .., ..
// . , 2009. 4. C. 7276.

..



. , .
.
Summary
R.K. Ashirova
Ointment "MODERM" In the tYpical treatment
of atopic dermatitis
The article describes the modern aspects of external treatment of atopic dermatitis, and describes
the technology of treatment of dermatosis with moderm cream.

139

 616-085: 614

2013, 5 (113)

.. , .. , ..
. .. , -
- , .

4-

: 4- .
: , , , .

. 800 .
(1640), .
: , , , , . ,
.
,
,
, .
. , , ,
[1, 2].

, 1- . ,
60 . ,
.
2- 1, . 2-
, ,
1 [3,4].
, . 4- () Burly.
4- , .

140

 50 : 20
, 30 .
, , 1, 3- 7- .
.
4- 1 (10 ) 1 10 . 4-,
, , .
(n=20) , , , . .
(n=30) ,
.
, 13 - . 55 105
Scorad.

4- 10
23- , 7-10- .
20 (100%) .
18 30 4-
5- , 9 7 8-. 3 .
, . . 10 , 60% , 25%, 10%.
4- 10 10 , ,
37 (74%) , 10 (20%), 3 (6%).
.

,
.
4- 50 . , 10- 5 100% (n=20) . 30
60%, 25%,
15%. 4-, ,
. -, , , -, 4-
20 , 1520 .
:
1. 4-
(, ).
2. 4-
, .
3. 4- .
141


1 .. . 1998. 146 .
2 .. . ., 2000. 118 .
3 .. , 1995. 254 .
4 .. : . , 2003. 98 .

.. , .. , ..
4-

4- 50
.
.
Summary
A.M. Ospanova, R.K. Ashirova, G.A. Tashbaeva
The clinical results of the drug 4-modenol used
in the combined treatment of allergic dermatoses
The clinical results of the drug 4-modenol used in the combined treatment of 50 patients with
allergic dermatoses were assessed. Twenty patients with eczema and 20 patients with atopic dermatitis
were followed up. The authors experience has indicated the efficacy and good tolerance of this drug,
which permits its use in dermatological practice in the out inpatient settings.

617.5- 08

2013, 5 (113)
..

, . . 1993 ,
300 , 15 600. , , , ,
, .
(. ) 30 . 600
493, 107. ,
, ,
, . 258, 65, . 270 IIIII .
,
(45 . ), , , , , , ,
.
, .
: , , , ., ., , , , .
26,
7 , - 24, 11, 26,
2 .

, . .
. 4 , - 8, 12.
, , 23
. 23 , 45
. 57 ,
23 , 143

 1012 , . 11 (1,7%) 8 ,
3 . 1 2 .
, , .
() ,
, 23 , .
, 3
.
, , , .

144